BOGANI, COSTANZA
 Distribuzione geografica
Continente #
NA - Nord America 2.183
EU - Europa 2.151
AS - Asia 715
SA - Sud America 81
AF - Africa 18
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.163
Nazione #
US - Stati Uniti d'America 2.170
PL - Polonia 1.043
RU - Federazione Russa 465
SG - Singapore 194
CN - Cina 176
HK - Hong Kong 155
SE - Svezia 146
IT - Italia 131
IE - Irlanda 128
BR - Brasile 69
DE - Germania 67
KR - Corea 57
GB - Regno Unito 41
VN - Vietnam 41
IN - India 38
FI - Finlandia 37
UA - Ucraina 30
CH - Svizzera 21
FR - Francia 14
JO - Giordania 14
AU - Australia 13
ID - Indonesia 10
BE - Belgio 9
CA - Canada 9
TR - Turchia 9
ES - Italia 7
AE - Emirati Arabi Uniti 5
NL - Olanda 5
AR - Argentina 4
BD - Bangladesh 4
CI - Costa d'Avorio 4
DZ - Algeria 3
LT - Lituania 3
MA - Marocco 3
ZA - Sudafrica 3
EC - Ecuador 2
EG - Egitto 2
IQ - Iraq 2
MX - Messico 2
UY - Uruguay 2
AT - Austria 1
BJ - Benin 1
BO - Bolivia 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
IL - Israele 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PW - Palau 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 5.163
Città #
Warsaw 1.042
Santa Clara 571
Fairfield 202
Ashburn 195
Chandler 137
Hong Kong 137
Dublin 128
Singapore 126
Woodbridge 101
Houston 90
Seattle 89
Cambridge 75
Wilmington 72
Beijing 67
Ann Arbor 59
Seoul 57
Jacksonville 55
Buffalo 40
Lawrence 33
Altamura 30
Princeton 30
Dallas 23
Florence 23
Los Angeles 23
Bern 21
Boston 21
Hefei 19
Boardman 18
Pune 18
Ho Chi Minh City 17
Bremen 15
Dong Ket 15
Mumbai 15
Munich 15
Shanghai 14
New York 13
Melbourne 12
San Diego 10
Turku 10
Brussels 9
Medford 9
Frankfurt am Main 8
Jakarta 8
London 8
Moscow 8
Phoenix 8
Clifton 6
Izmir 6
Salerno 6
Andover 5
Kent 5
Rignano sull'Arno 5
São Paulo 5
Abidjan 4
Abu Dhabi 4
Cagliari 4
Falls Church 4
Montreal 4
Norwalk 4
Prato 4
The Dalles 4
West Jordan 4
Basauri 3
Brooklyn 3
Cavriago 3
Chicago 3
Frankfurt Am Main 3
Hangzhou 3
Hanoi 3
Hillsboro 3
Manchester 3
Naples 3
Redondo Beach 3
Sétif 3
Amman 2
Ariano Irpino 2
Atlanta 2
Barcelona 2
Belo Horizonte 2
Bitonto 2
Brasília 2
Caldiero 2
Chennai 2
Cremona 2
Dhaka 2
Elk Grove Village 2
Franca 2
Guangzhou 2
Hebei 2
Helsinki 2
Juiz de Fora 2
Milan 2
Montevarchi 2
Raleigh 2
Redwood City 2
Roubaix 2
Salt Lake City 2
San Jose 2
São Gonçalo 2
São José dos Campos 2
Totale 3.858
Nome #
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives 315
Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial 315
Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. 315
mTOR inhibitors alone and in combination with JAK2 inhibitors effectively inhibit cells of myeloproliferative neoplasms. 306
Caratterizzazione di alterazioni molecolari relative alla patogenesi delle Neoplasie Mieloproliferative Croniche 295
Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis 294
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosis. 287
Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis. 274
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils of polycythemia vera. 264
Overexpression of microRNA-16-2 contributes to the abnormalerythropoiesis in polycythemia vera. 201
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). 201
MicroRNA expression profile in granulocytes from primary myelofibrosis patients. 189
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 183
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. 176
Inconsistencies in the association between the JAL2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases 175
Mitochondrial expression and functional activity of Breast Cancer Resistance Protein in different multiple drug-resistant cell lines 168
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. 167
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 163
Preclinical models for drug selection in myeloproliferative neoplasms. 144
Breast cancer resistance protein (BCRP) expression and activity in mitochondria of different multiple drug-resistant (MDR) cancer cell lines 143
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells unveils the role of miR-155/JARID2 axis in abnormal megakaryopoiesis. 141
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden. 137
JAK PI3K/mTOR COMBINATION THERAPY 128
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis 115
mTOR/JAK INHIBITOR COMBINATION THERAPY 108
Totale 5.204
Categoria #
all - tutte 12.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 0 0 0 46 21 34 41 55 27 31
2021/2022228 7 12 31 11 9 13 5 16 8 12 47 57
2022/2023572 48 112 26 57 49 93 67 43 40 6 8 23
2023/2024203 6 20 27 18 22 58 3 31 2 2 8 6
2024/20251.432 23 139 86 193 422 256 18 92 59 20 50 74
2025/2026673 177 160 100 77 149 10 0 0 0 0 0 0
Totale 5.204